Clinical Services: Servic Name

Headline

Some Description

METRICS OR KEY SENTENCE ABOUT BENEFITS

Benefits, description etc.

Tools & TEmplate or featured Video or other Resource

Headline
Subheadline or sentence of some kind to describe
DOWNLOAD FACTSHEET

Process Option One

Process Item Description
Learn More
Process Item Description
Learn More
Process Item Description
Learn More
Process Item Description
Learn More
Process Item Description
Learn More
01.
EARLY CLINICAL DEVELOPMENT
02.
CLINICAL CRO DELIVERY
03.
CONSULTING

Process Option 2

Our team of therapeutic and operational experts can support all aspects of clinical and commercial operations, allowing for easier innovation and earlier access to market.

Our trial delivery focuses on agility, efficiency, speed, and a deep understanding of cardiovascular endpoints. We work with class II and class III devices, whether they support a 510(k), PMA, post approval, or observational assessment.

Topic

Headline one
Headline two
Paragraph of descritpion
Partner with an expert that understands your innovation

Deliverables

Headline
Headline two
Main Topic
Item
Item
Item
Item
Item
Item
Item
Item
Main Topic
Item
Item
Item
Item
Item
Item
Item
Item
"The projects are very interesting as they deal a lot with niche products, and products that are seeking for a market. The people are fantastic, funny, open minded, tolerant, adorable, intelligent, competent, but above all they are motivated."
Position
First & Last Name
"The projects are very interesting as they deal a lot with niche products, and products that are seeking for a market. The people are fantastic, funny, open minded, tolerant, adorable, intelligent, competent, but above all they are motivated."
Position
First & Last Name
“Proxima has been such a wonderful help every step of the way. Everyone is truly great to work with.”
Junior Project Engineer
Karen Wells
We have had the pleasure of working with the Proxima team for over a year on overall regulatory strategy and support for FDA interactions. The entire Proxima team are unbelievably knowledgeable in this space with excellent communication skills, highly strategic thinking, and amazing customer service. We at Prenosis highly recommend them as a one stop shop for anything regulatory or clinical trial related, all offered at a very attractive price point.
CEO and Co-Founder
Bobby Reddy Jr.
Proxima has been an important piece of Memgen's regulatory and clinical achievements for multiple years now, playing a vital role in our IND approval, clinical launch, and trial management of our first-in-human study of our lead cancer immunotherapy biologic. Proxima and its growing team have continually shown their experience, broad skill sets, adaptability to our company's needs and objectives, and value in an industry with a myriad of CROs to choose from.
CSO
Mark Cantwell
"Proxima has been attentive to a variety of our regulatory related needs. From coordinating studies with aggressive timelines to assisting with sales aid approvals, they have always delivered. As we launched our first in class/disease product, we needed a high touch clinical research and regulatory partner, and Proxima has provided that for us."
Founder & CEO
Robert Whitehead
We joined forces with Proxima's Quality Consultants to ready ourselves for upcoming audits of both our QMS and our parent company's QMS. Their approachable, expert team delivered essential support and insightful guidance, never shying away from directing us confidently towards the right path. We are proud to share our spotless ISO 13485 recertification audit, a testament to Proxima's steadfast commitment and fearless leadership!
Regulatory & QA Manager
Michael Selva
“As a busy surgeon developing a Class III implantable device I needed help with regulatory strategy and execution. I wanted someone that was as passionate about the device as I was and that could hit the ground running. Because PROXIMA supports emerging companies through Med Tech Innovator they were a perfect fit. Isabella also helped us manage other vendor relationships and kept things moving forward. I been very happy working with PROXIMA”
Founder
Marc Bessler, M.D.
Proxima was instrumental to our success in getting breakthrough device designation for our product! The team was very knowledgeable and responsive and set us up for success. They made the FDA process easy to go through and prepared us for future interactions with FDA.
Co-Founder
Jade Doucet-Martineau
"The wonderful people at Proxima have been dogged champions for our success. Aside from being deeply experienced in our particular field and keenly knowledgeable on developing trends they take our success as personally as we do. That, as much as anything, has been the difference."
COO & Co-Founder
Geoffrey Lucks
Developing medical technology for children has unique challenges. The Southwest National Pediatric Device Innovation Consortium (SWPDC) is a consortium supported by an FDA grant to assist innovators with their pediatric device development as well as address their regulatory challenges. Proxima has been a strong partner for us in helping guide innovators quickly through their regulatory and clinical journey.
Physician
Chester J. Koh, MD
Headline for CTA
Some kind of CTA continuation
Speak with a [SERVICE] expert

FREQUENTLY ASKED QUESTIONS

What is a Pre-Sub?
Learn More

Glossary

Sunshine Act
Learn More

Latest INsight

Isabella Schmitt Weighs In On IoT Innovation In Recent CMSWire Feature
Learn More

Latest Video

Top 5 Considerations When Selecting a CRO for MedTech or Biotech Companies
Learn More